000			01967 a2200637 4500
005			20250516230012.0
264		0	_c20150420
008			201504s 0 0 eng d
022			_a1471-2407
024	7		_a10.1186/1471-2407-14-586 _2doi
040			_aNLM _beng _cNLM
100	1		_aKhor, Sara
245	0	0	_aReal world costs and cost-effectiveness of Rituximab for diffuse large B-cell lymphoma patients: a population-based analysis. _h[electronic resource]
260			_bBMC cancer _cAug 2014
300			_a586 p. _bdigital
500			_aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAdolescent
650	0	4	_aAdult
650	0	4	_aAge Factors
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aAntibodies, Monoclonal, Murine-Derived _xeconomics
650	0	4	_aAntineoplastic Agents _xeconomics
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xeconomics
650	0	4	_aChild
650	0	4	_aChild, Preschool
650	0	4	_aCost-Benefit Analysis
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aInfant
650	0	4	_aLymphoma, Large B-Cell, Diffuse _xdrug therapy
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aModels, Economic
650	0	4	_aOntario
650	0	4	_aRituximab
650	0	4	_aSurvival Rate
650	0	4	_aYoung Adult
700	1		_aBeca, Jaclyn
700	1		_aKrahn, Murray
700	1		_aHodgson, David
700	1		_aLee, Linda
700	1		_aCrump, Michael
700	1		_aBremner, Karen E
700	1		_aLuo, Jin
700	1		_aMamdani, Muhammad
700	1		_aBell, Chaim M
700	1		_aSawka, Carol
700	1		_aGavura, Scott
700	1		_aSullivan, Terrence
700	1		_aTrudeau, Maureen
700	1		_aPeacock, Stuart
700	1		_aHoch, Jeffrey S
773	0		_tBMC cancer _gvol. 14 _gp. 586
856	4	0	_uhttps://doi.org/10.1186/1471-2407-14-586 _zAvailable from publisher's website
999			_c24093163 _d24093163